insides_and_recomendations
- 2024-12-04study
CHAI’s 2024 HIV Market Report
The Clinton Health Access Initiative (CHAI) has released its 2024 HIV Market Report, a detailed resource that provides updated data and insights on HIV diagnosis, treatment, and prevention in low- and middle-income countries. Authored by CHAI, this comprehensive publication highlights the impact of innovative HIV products on patient outcomes, market trends, and global funding strategies. Read the full report on the official CHAI website:
- 2023-10-31success-story
CHAI’s 2023 HIV Market Report
CHAI has also published the 2023 HIV Market Report, offering an in-depth look at evolving market dynamics across low- and middle-income countries. Authored by the same team, this publication explores key developments in antiretroviral therapies, strategic approaches to procurement and pricing, and collaborative efforts to improve accessibility. The full 2023 report is available here:
- 2021-02-22 15:55:00success-story
Ruslan Poverga: “When circumstances force, everything is resolved quickly.
This interview, featured on the Alliance for Public Health (APH) website and authored by APH, delves into how pressing conditions can propel swift and effective solutions in public health. Ruslan Poverga discusses the importance of rapid mobilization, resource coordination, and adaptive strategies when responding to urgent challenges, underscoring how crisis situations often highlight the resilience and flexibility of healthcare systems. Read the full story here:
- 2021-02-22 15:55:00success-story
The Economist Intelligence Unit: The Global Impact of ART on HIV.
Published by The Economist Intelligence Unit (EIU), this report provides an in-depth exploration of how antiretroviral therapy (ART) has transformed the global landscape of HIV prevention and treatment. Drawing on data from multiple regions, the authors examine both the monumental progress achieved—such as reduced mortality rates and improved quality of life—and the pressing challenges that remain. This comprehensive analysis sheds light on innovative strategies to expand access, improve outcomes, and sustain funding for HIV care worldwide. Access the final PDF here:
- 2021-06-29success-story
Moldova Strives to Make Health Procurement More Sustainable
This United Nations Development Programme (UNDP) article, authored by UNDP Moldova, highlights the country’s ongoing efforts to integrate sustainability principles into the procurement of healthcare goods and services. The piece describes initiatives aimed at reducing environmental impact, promoting cost-effectiveness, and strengthening transparency within Moldova’s public health system. It also discusses how local stakeholders collaborate with international partners to ensure that reforms lead to equitable and lasting improvements. Full details available at:
- 2021-08-08success-story
Analysis of Procurement in Kyrgyzstan and Moldova (2021–2022).
Presented by the Health Advocacy Coalition (HAC), this comprehensive review investigates procurement practices in Kyrgyzstan and Moldova, focusing on efficiency, transparency, and overall impact on health systems. Authored by HAC, the report uncovers key achievements, identifies bottlenecks, and offers actionable recommendations for stakeholders aiming to optimize public spending and strengthen healthcare services. Read more:
- 2021-03-21success-story
E-Procurement: A Tool for Improving Transparency
In this publication by The German Marshall Fund of the United States (GMF), the authors examine how electronic procurement systems can reshape public sector purchasing by reducing corruption risks, improving accountability, and increasing efficiency. Drawing on real-world examples, the report illustrates the broad potential of digital solutions to modernize governance, streamline processes, and foster public trust. Access the full PDF here:
- 2025-01-16success-story
Ukrainian Patient Rights Group Opposes a Patent Application on a Life-Saving HIV Drug.
A Ukrainian patient rights organization is actively challenging a patent application for a crucial HIV medication, arguing that exclusive intellectual property rights could significantly inflate treatment costs and limit access for those most in need. Their position stresses the delicate balance between encouraging pharmaceutical innovation and ensuring that life-saving treatments remain affordable. By highlighting the potential human impact of restrictive patent laws, the group seeks to spark a broader conversation on how legal frameworks can either support or hinder public health objectives, especially in countries with limited resources. This debate resonates with global discussions on equitable healthcare, where advocacy groups and civil society organizations strive to safeguard patient interests. The Ukrainian campaign underscores the importance of transparency, legal scrutiny, and community-driven activism in shaping policies that affect the well-being of millions. Read more:
- 2022-04-14success-story
Life-Saving Logistics in Ukraine
An in-depth feature by UNAIDS sheds light on the extraordinary efforts to maintain the supply of HIV medicines and other essential healthcare commodities in conflict-affected areas of Ukraine. Even amid escalating challenges, local groups collaborate with international partners to orchestrate complex delivery routes, manage inventory under uncertain conditions, and ensure that life-saving treatments reach those at risk. Such logistical coordination often makes the difference between uninterrupted care and life-threatening drug shortages. From deploying mobile clinics to establishing temporary distribution hubs, every measure taken helps safeguard vulnerable communities. This story highlights not just the resiliency of Ukraine’s healthcare sector but also the global solidarity fueling emergency operations. It underscores how, with the right support and organization, vital medical supplies can flow even in the harshest environments. Read more:
- 2021-07-01success-story
ART Procurement and Supply in Ukraine
The Public Health Center of the Ministry of Health of Ukraine offers detailed insight into how antiretroviral therapy (ART) procurement and distribution are managed. Their approach includes forecasting patient demand, streamlining tender processes, and tracking medication inventories to minimize risks of stockouts. Collaboration with international donors and NGOs further bolsters Ukraine’s capacity to meet diverse patient needs while maintaining cost-effectiveness and transparency. These efforts reflect the broader commitment to building a resilient health infrastructure that can adapt to evolving challenges, from financial constraints to geopolitical tensions. By sharing best practices and real-life success stories, the Public Health Center underscores that robust governance and consistent oversight are pivotal for sustained ART coverage. Read more:
- 2022-05-03success-story
HIV Drugs Have Reached Ukraine, but That’s Not the End of the Problem
This Devex article dives into the persistent hurdles facing Ukraine’s health system after shipments of vital HIV medications arrived in the country. It highlights that while securing medical supplies is a major victory, effectively distributing these treatments and ensuring consistent follow-up care in conflict-affected regions can be just as challenging. Transport disruptions, security risks, and limited clinical access all play a role in complicating patient adherence. The report showcases how NGOs, donors, and local authorities collaborate to triage and respond to on-the-ground realities. By mapping out possible routes, employing flexible delivery methods, and expanding telemedicine resources, they try to bridge gaps in service provision. Ultimately, the story underscores the multi-layered nature of public health work in crisis settings, where timely medication is only one piece of a much larger puzzle. Read more:
- 2022-05-03success-story
The Global HIV/AIDS Epidemic: How the UN Is Trying to Overcome It by 2030 Despite Russian Sabotage
ZMINA presents a thorough examination of the United Nations’ ambitious agenda to end the HIV/AIDS epidemic by 2030 and the multifaceted obstacles obstructing progress, including geopolitical tensions linked to Russian aggression. The article underscores the importance of sustained funding, groundbreaking research, and inclusive policies, all designed to broaden testing, prevention, and treatment services. At the heart of this effort is a diverse network of local communities, NGOs, and global partners dedicated to upholding the “90–90–90” objectives—ensuring that 90% of people living with HIV know their status, 90% are on treatment, and 90% achieve viral suppression. Despite mounting challenges, the determination to fulfill these goals remains strong, providing a powerful example of coordinated international action in the face of adversity. Read more:
- 2021-02-22success-story
Fight for Life: How Ukraine Is Fixing Medical Procurement and Serving Patients Better
This feature from the Open Contracting Partnership spotlights Ukraine’s transformative approach to medical procurement, which integrates open contracting data, community oversight, and fair competitive bidding. By exposing previously opaque processes to public scrutiny, the country has reduced costs, improved quality control, and enhanced the reliability of drug deliveries for patients with chronic or life-threatening conditions, such as HIV/AIDS. Real-world examples demonstrate that these changes aren’t just theoretical—they translate into more timely availability of drugs, less corruption, and a renewed sense of trust in public institutions. The article reinforces how transparent and well-monitored procurement is a cornerstone of comprehensive healthcare reform, benefiting both patients and the broader society. Read more:
- 2024-12-04success-story
How to Make Better Public Procurement Decisions with Business Intelligence: Insights from Ukraine
Another insightful piece from the Open Contracting Partnership demonstrates how business intelligence tools, real-time dashboards, and data analytics can revolutionize public procurement. By aggregating procurement data, officials in Ukraine can identify spending anomalies, forecast demand more accurately, and allocate resources more effectively to pressing healthcare needs. This data-centric method also helps reduce corruption risks, ensuring that funds earmarked for essential medical supplies are used responsibly. As governments worldwide look to modernize procurement systems, Ukraine’s experience serves as a compelling example of how technology, transparency, and collaboration can drive tangible improvements in the public sector. Read more:
- 2024-12-04success-story
Post-War Procurement: How Ukraine Can Ensure the Reconstruction Is Transparent and Effective
This publication from the Open Contracting Partnership delves into the challenges and opportunities Ukraine faces in the wake of conflict, particularly in rebuilding vital infrastructure. Through transparent procurement processes, multi-stakeholder collaboration, and proactive oversight, the country can optimize the allocation of resources to accelerate reconstruction while reducing waste and corruption. The piece further highlights how public confidence in rebuilding efforts is contingent on open governance and accountability. As global donors and local agencies collaborate on large-scale restoration projects, maintaining robust procurement protocols will be key to forging a healthier, more resilient Ukraine. Read more:
- 2023-11-23success-story
Patients, Experts, and Openness: A Powerful Combination Therapy for Unaffordable Medicines in Moldova
In this account from the Open Contracting Partnership, Moldova demonstrates how a coalition of patients, medical professionals, and government officials can tackle the high cost of essential medications. By adopting open contracting, stakeholders gain visibility into pricing structures, root out irregularities, and negotiate more affordable terms for life-saving drugs. This cooperative model underscores how transparency, community involvement, and data-driven policies can substantially reduce healthcare expenses. The result is improved access to crucial treatments, benefitting both individual patients and national health outcomes—a powerful lesson for other nations grappling with unaffordable medicines. Read more: